Yassa Leila, Cibas Edmund S, Benson Carol B, Frates Mary C, Doubilet Peter M, Gawande Atul A, Moore Francis D, Kim Brian W, Nosé Vânia, Marqusee Ellen, Larsen P Reed, Alexander Erik K
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Cancer. 2007 Dec 25;111(6):508-16. doi: 10.1002/cncr.23116.
The diagnostic evaluation of patients with thyroid nodules is imprecise. Despite the benefits of fine-needle aspiration (FNA), most patients who are referred for surgery because of abnormal cytology prove to have benign disease. Recent technologic and procedural advances suggest that this shortcoming can be mitigated, although few data confirm this benefit in unselected patients.
A total of 2587 sequential patients were evaluated by thyroid ultrasound and were offered ultrasound-guided FNA (UG-FNA) of all thyroid nodules that measured > or =1 cm during a 10-year period. Results of aspiration cytology were correlated with histologic findings. The prevalence of thyroid cancer in all patients and in those who underwent surgery was determined. Surgical risk was calculated.
Tumors that measured > or =1 cm were present in 14% of patients: Forty-three percent of patients had tumors that measured <2 cm in greatest dimension, and 93% had American Joint Committee on Cancer stage I or II disease. The cytologic diagnoses 'positive for malignancy' and 'no malignant cells' were 97% predictive and 99.7% predictive, respectively. Repeat FNA of initial insufficient aspirates, as well as more detailed classification of inconclusive aspirates, improved preoperative assessment of cancer risk and reduced surgical intervention. Fifty-six percent of patients who were referred for surgery because of abnormal cytology had cancer compared with from 10% to 45% of patients historically. An analysis of operative complications from a subset of 296 patients demonstrated a 1% risk of permanent surgical complications.
The current findings demonstrated the benefits of UG-FNA and of a more detailed classification of inconclusive aspirates in the preoperative risk assessment of thyroid nodules, supporting adherence to recently published guidelines.
甲状腺结节患者的诊断评估并不精确。尽管细针穿刺抽吸活检(FNA)有诸多益处,但大多数因细胞学异常而被转诊接受手术的患者最终被证明患有良性疾病。近期的技术和操作进展表明,这一缺陷可以得到缓解,不过很少有数据能证实这对未经筛选的患者有益。
在10年期间,对总共2587例连续患者进行了甲状腺超声检查,并对所有直径≥1厘米的甲状腺结节进行超声引导下细针穿刺抽吸活检(UG-FNA)。穿刺细胞学检查结果与组织学结果相关联。确定了所有患者以及接受手术患者中甲状腺癌的患病率。计算了手术风险。
14%的患者存在直径≥1厘米的肿瘤:43%的患者肿瘤最大直径<2厘米,93%的患者患有美国癌症联合委员会I期或II期疾病。细胞学诊断“恶性阳性”和“无恶性细胞”的预测准确率分别为97%和99.7%。对最初抽吸不足的样本进行重复FNA,以及对不确定抽吸样本进行更详细的分类,改善了癌症风险的术前评估并减少了手术干预。因细胞学异常而被转诊接受手术的患者中,56%患有癌症,而历史上这一比例为10%至45%。对296例患者子集手术并发症的分析表明,永久性手术并发症的风险为1%。
目前的研究结果表明,UG-FNA以及对不确定抽吸样本进行更详细的分类在甲状腺结节术前风险评估中具有益处,支持遵循最近发布的指南。